Gardasil-9 Approved for Prevention of Head and Neck Cancers
The US Food and Drug Administration (FDA) has expanded the indication for the Gardasil-9 (Merck) vaccine to include prevention of oropharyngeal and other head and neck cancers caused by HPV types 16, 18, 31, 33, 45, 52, and 58. This new indication is approved under the FDA’s accelerated approval program and is based on the… Read More »Gardasil-9 Approved for Prevention of Head and Neck Cancers